Adapted cells were used to perform cumulative growth assays under hypoxic conditions and demonstrating that PDP1 knockdown caused a similar growth disadvantage in FLT3-ITD-positive AML cells as under normoxic conditions (Fig. 6A). The gene discussed is FLT3; the disease is acute myeloid leukemia.